Skip to main content

Adicet Bio, Inc.

ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001720580

No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.

13F holders, Q3 2023

Institutional positions in Adicet Bio, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
84
−10 vs. Q2 2023
Shares held
35.7M
−1.44M (−3.9%) vs. Q2 2023
Total value
$48.9M
−$41.4M (−45.9%) vs. Q2 2023
New holders
13
30 more added
Sold out
23
22 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACET on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 84 institutions
Q1 2021: 54 institutionsQ2 2021: 66 institutionsQ3 2021: 58 institutionsQ4 2021: 81 institutionsQ1 2022: 88 institutionsQ2 2022: 101 institutionsQ3 2022: 102 institutionsQ4 2022: 100 institutionsQ1 2023: 107 institutionsQ2 2023: 95 institutionsQ3 2023: 84 institutionsQ4 2023: 77 institutionsQ1 2024: 98 institutionsQ2 2024: 86 institutionsQ3 2024: 64 institutionsQ4 2024: 64 institutionsQ1 2025: 56 institutionsQ2 2025: 49 institutionsQ3 2025: 54 institutionsQ4 2025: 49 institutionsQ1 2026: 49 institutionsQ2 2026: 56 institutions
Value heldQ3 2023: $48.9M
Q1 2021: $266.3MQ2 2021: $218.1MQ3 2021: $156.1MQ4 2021: $531.2MQ1 2022: $660.4MQ2 2022: $555.9MQ3 2022: $590.7MQ4 2022: $375.7MQ1 2023: $231.3MQ2 2023: $90.4MQ3 2023: $48.9MQ4 2023: $63.0MQ1 2024: $176.6MQ2 2024: $77.4MQ3 2024: $82.3MQ4 2024: $55.4MQ1 2025: $42.0MQ2 2025: $31.5MQ3 2025: $41.6MQ4 2025: $56.6MQ1 2026: $43.7MQ2 2026: $52.8M
Institutions holding ACET and their total value by quarter
QuarterHoldersValue
Q2 202656$52.8M
Q1 202649$43.7M
Q4 202549$56.6M
Q3 202554$41.6M
Q2 202549$31.5M
Q1 202556$42.0M
Q4 202464$55.4M
Q3 202464$82.3M
Q2 202486$77.4M
Q1 202498$176.6M
Q4 202377$63.0M
Q3 202384$48.9M
Q2 202395$90.4M
Q1 2023107$231.3M
Q4 2022100$375.7M
Q3 2022102$590.7M
Q2 2022101$555.9M
Q1 202288$660.4M
Q4 202181$531.2M
Q3 202158$156.1M
Q2 202166$218.1M
Q1 202154$266.3M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Adicet Bio, Inc.; share changes are against Q2 2023.

Institutions holding ACET in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Mirae Asset Global Investments Co., Ltd.0$00.00%−12,804−100.0%Sold out
Voya Investment Management LLC0$00.00%−12,359−100.0%Sold out
Walleye Capital LLC0$00.00%−10,002−100.0%Sold out
Public Employees Retirement System of Ohio0$00.00%−4,070−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−1,319−100.0%Sold out
Red Tortoise LLC0$00.00%−649−100.0%Sold out
Impact Partnership Wealth, LLC0$00.00%−67−100.0%Sold out
Tekla Capital Management LLC––––Not filed